StockData
PROCEPT BioRobotics Corp logo

PROCEPT BioRobotics Corp (PRCT) stock

PRCTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 9/3051% below fair value
$23.51+0.17 (+0.73%)

Close on Nov 12, 2026Market cap $1.35BP/E –Yield –

PROCEPT BioRobotics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

PROCEPT BioRobotics's profit margin for the twelve months ending Sep 30, 2026 was -32.6%. For fiscal 2025 it was -31.0%, against -40.7% the year before. The highest annual figure on record is -31.0% in fiscal 2025.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-31.0%+9.7
FY2024Dec 31, 2024-40.7%+37.0
FY2023Dec 31, 2023-77.8%+38.4
FY2022Dec 31, 2022-116.2%+57.4
FY2021Dec 31, 2021-173.6%+513.4
FY2020Dec 31, 2020-687.0%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-27.0%−1.3
Q2 FY2026Jun 30, 2026-28.4%−3.7
Q1 FY2026Mar 31, 2026-38.1%−2.3
Q4 FY2025Dec 31, 2025-39.1%−11.4
Q3 FY2025Sep 30, 2025-25.7%+10.2
Q2 FY2025Jun 30, 2025-24.7%+23.3
Q1 FY2025Mar 31, 2025-35.8%+22.5
Q4 FY2024Dec 31, 2024-27.6%+35.5
Q3 FY2024Sep 30, 2024-35.9%+34.2
Q2 FY2024Jun 30, 2024-48.0%+28.3
Q1 FY2024Mar 31, 2024-58.3%+58.4
Q4 FY2023Dec 31, 2023-63.1%+55.4
Q3 FY2023Sep 30, 2023-70.1%+41.0
Q2 FY2023Jun 30, 2023-76.4%+38.6
Q1 FY2023Mar 31, 2023-116.7%+4.3
Q4 FY2022Dec 31, 2022-118.5%+62.5
Q3 FY2022Sep 30, 2022-111.1%+51.6
Q2 FY2022Jun 30, 2022-114.9%+57.1
Q1 FY2022Mar 31, 2022-121.0%+57.2
Q4 FY2021Dec 31, 2021-181.0%+293.3
Q3 FY2021Sep 30, 2021-162.7%+407.2
Q2 FY2021Jun 30, 2021-172.0%–
Q1 FY2021Mar 31, 2021-178.3%–
Q4 FY2020Dec 31, 2020-474.3%–
Q3 FY2020Sep 30, 2020-569.9%–

More PROCEPT BioRobotics figures

See a number that looks wrong?